In Collaboration with Astellas, Affinivax, Inc. Announces Initiation of Phase 1/2 Clinical Study of ASP3772, its novel…
Affinivax is advancing a next generation vaccine technology platform to enable the development of vaccines that provide the highest level of protection against challenging…